Catalyst Wire Dossier Catalyst Wire Dossier

DW9801

· Daewon Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DW9801, covering 2020-09-09 to 2020-09-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients With Primary Dysmenorrhea [Phase 3]

See pricing